Integrative genomic identification of therapeutic targets for pancreatic cancer
Jimmy A. Guo(Broad Institute), Andrew J. Aguirre(Broad Institute), Carina Shiau(Broad Institute), Julien Dilly(Massachusetts Institute of Technology), Seema Chugh(Broad Institute), Harshabad Singh(Brigham and Women's Hospital), William L. Hwang(Massachusetts General Hospital), Francisca Vázquez(Broad Institute), Patrick Yu(University of Washington), Daniel Zhao(New York Medical College), Kyle E. Evans(Broad Institute), Joseph D. Mancias(Brigham and Women's Hospital), Ananya Jambhale(New York University), Eric L. Smith(Dana-Farber Cancer Institute), Peter Chen(Cedars-Sinai Medical Center), Wenzhuo Wu(Harvard University), Kazuki Takahashi(University of Occupational and Environmental Health Japan), Dennis Gong(Broad Institute), Steven Wang, Kevin S. Kapner(Broad Institute)
Cited by 7
Related Papers
Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
|Genes & Development|2003|1k
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
|Nature Cancer|2020|880
Phosphorylation of the PTEN Tail Regulates Protein Stability and Function
|Molecular and Cellular Biology|2000|779
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632